Publications by authors named "Basem William"

67Publications

Autologous stem cell transplant in first remission for transformed indolent non-Hodgkin lymphoma: additional data to guide practice.

Br J Haematol 2020 Oct 16. Epub 2020 Oct 16.

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.

View Article and Find Full Text PDF
October 2020

Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.

Biol Blood Marrow Transplant 2020 Aug 15;26(8):e198-e201. Epub 2020 Apr 15.

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.

View Article and Find Full Text PDF
August 2020

A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia.

Clin Lymphoma Myeloma Leuk 2020 04 6;20(4):226-233.e1. Epub 2019 Nov 6.

Division of Hematology and Oncology, Department of Medicine, Seidman Cancer Center, Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH. Electronic address:

View Article and Find Full Text PDF
April 2020

Dramatic and Durable Responses to Romidepsin in Two Patients With the Lymphocytic Variant of Hypereosinophilic Syndrome.

Clin Lymphoma Myeloma Leuk 2020 03 9;20(3):e128-e130. Epub 2019 Nov 9.

Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH. Electronic address:

View Article and Find Full Text PDF
March 2020

Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2019 10 20;25(10):1993-2001. Epub 2019 Jun 20.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address:

View Article and Find Full Text PDF
October 2019

Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma.

J Invest Dermatol 2019 09 12;139(9):1966-1974.e3. Epub 2019 Mar 12.

Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA; Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, USA; Division of Dermatology, Department of Internal Medicine, Ohio State University, Columbus, Ohio, USA. Electronic address:

View Article and Find Full Text PDF
September 2019

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.

Leuk Lymphoma 2019 09 15;60(9):2223-2229. Epub 2019 Feb 15.

Department of Pharmacy, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.

View Article and Find Full Text PDF
September 2019

Low-Dose Azacitidine with DNMT1 Level Monitoring to Treat Post-Transplantation Acute Myelogenous Leukemia or Myelodysplastic Syndrome Relapse.

Biol Blood Marrow Transplant 2019 06 30;25(6):1122-1127. Epub 2018 Dec 30.

University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Cleveland, Ohio. Electronic address:

View Article and Find Full Text PDF
June 2019

An LC-MS/MS method for simultaneous determination of curcumin, curcumin glucuronide and curcumin sulfate in a phase II clinical trial.

J Pharm Biomed Anal 2018 Jul 23;156:189-198. Epub 2018 Apr 23.

Department of Chemistry, Cleveland State University, 2121 Euclid Avenue, Cleveland, OH 44115, United States; Case Comprehensive Cancer Center, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH 44106, United States. Electronic address:

View Article and Find Full Text PDF
July 2018

Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib.

Cancer Manag Res 2018 27;10:615-624. Epub 2018 Mar 27.

Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center (OSUCCC-James), The Ohio State University, Columbus, OH, USA.

View Article and Find Full Text PDF
March 2018

Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy.

Curr Oncol Rep 2018 03 23;20(4):33. Epub 2018 Mar 23.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center (OSUCCC-James), 320 W. 10th Avenue, A352, Columbus, OH, 43210, USA.

View Article and Find Full Text PDF
March 2018

Waldenström's macroglobulinemia masquerading as ovarian cancer with peritoneal carcinomatosis, ascites, and elevated CA-125.

Hematol Oncol Stem Cell Ther 2019 Mar 31;12(1):54-59. Epub 2017 Mar 31.

Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, A352 Starling Loving Hall, 320 W. 10th Avenue, Columbus, OH 43210, USA.

View Article and Find Full Text PDF
March 2019

Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience.

Rev Bras Hematol Hemoter 2016 Oct - Dec;38(4):314-319. Epub 2016 Aug 18.

University Hospitals Case Medical Center, Cleveland, United States; Case Western Reserve University, Cleveland, United States. Electronic address:

View Article and Find Full Text PDF
August 2016

Bortezomib for the treatment of mantle cell lymphoma: an update.

Ther Adv Hematol 2016 Aug 21;7(4):196-208. Epub 2016 May 21.

Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, A352 Starling Loving Hall, 320 West 10th Avenue, Columbus, OH 43210, USA.

View Article and Find Full Text PDF
August 2016

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

J Clin Oncol 2016 06 4;34(16):1864-71. Epub 2016 Apr 4.

Brian C. Shaffer and Martin Tallman, Memorial Sloan Kettering Cancer Center; Adriana K. Malone, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai; Ran Reshef, Columbia University Medical Center, New York; Mark Litzow, Mayo Clinic Rochester; Jane Liesveld, University of Rochester Medical Center, Rochester; Peter H. Wiernik, Our Lady of Mercy Medical Center, Bronx, NY; Kwang Woo Ahn, Zhen-Huan Hu, and Wael Saber, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Taiga Nishihori and Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David Valcárcel, Hospital Vall d'Hebron, Barcelona, Spain; Michael R. Grunwald, Omotayo Fasan, and Edward Copelan, Levine Cancer Institute, Carolinas HealthCare System, Charlotte; William Allen Wood, University of North Carolina at Chapel Hill, Chapel Hill; David A. Rizzieri, Duke University Medical Center, Durham, NC; Ulrike Bacher, University of Medicine Göttingen, Göttingen, Germany; Betty Hamilton and Aaron Gerds, Cleveland Clinic Taussig Cancer Institute; Matt Kalaycio and Ron Sobecks, Cleveland Clinic Foundation, Cleveland; Basem William, Ohio State University Medical Center, Columbus, OH; Ayman Saad and Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Corey Cutler and Edwin Alyea, Dana-Farber Cancer Institute, Boston, MA; Erica Warlick and Celalettin Ustun, University of Minnesota Medical Center, Minneapolis, MN; Baldeep Mona Wirk, Seattle Cancer Care Alliance, Seattle, WA; Mitchell Sabloff, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario; Andrew Daly, Tom Baker Cancer Center, Calgary, Alberta, Canada; David Marks, University Hospitals Bristol National Health Service Trust, Bristol; Robert Peter Gale, Imperial College London, London, United Kingdom; Richard Olsson, Karolinska Institutet, Stockholm, Sweden; Alan M. Miller, Baylor University Medical Center; Rammurti Kamble

View Article and Find Full Text PDF
June 2016

Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.

Clin Lymphoma Myeloma Leuk 2015 Dec 5;15(12):748-52. Epub 2015 Aug 5.

Onco-cardiology program, Harrington Heart and Vascular Institute, and Seidman Cancer Center, University Hospitals, Cleveland, OH; School of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH; University Hospitals Seidman Cancer Center, Cleveland, OH. Electronic address:

View Article and Find Full Text PDF
December 2015

Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders.

Hematology 2016 May 15;21(4):218-24. Epub 2015 Jul 15.

b Department of Genetics, Cell Biology and Anatomy , University of Nebraska Medical Center , Omaha , USA.

View Article and Find Full Text PDF
May 2016

Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.

Biol Blood Marrow Transplant 2015 Nov 16;21(11):1926-31. Epub 2015 Jun 16.

Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Cleveland, Ohio.

View Article and Find Full Text PDF
November 2015

Azacitidine and Allogeneic Stem Cell Transplantation: When and Why?

Authors:
Basem M William

Acta Haematol 2015 6;134(1):38-9. Epub 2015 Jun 6.

Department of Medicine, Stem Cell Transplantation Program, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.

View Article and Find Full Text PDF
July 2015

Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better?

Leuk Lymphoma 2015 Mar 20;56(3):555-6. Epub 2014 Aug 20.

Stem Cell Transplantation Program, Department of Medicine, University Hospitals Seidman Cancer Center, Case Western Reserve University , Cleveland, OH , USA.

View Article and Find Full Text PDF
March 2015

Transmission of lupus anticoagulant by allogeneic stem cell transplantation.

Rev Bras Hematol Hemoter 2014 Jul-Aug;36(4):287-9. Epub 2014 May 29.

University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, United States.

View Article and Find Full Text PDF
July 2014

Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.

Biol Blood Marrow Transplant 2014 Apr 14;20(4):536-42. Epub 2014 Jan 14.

Division of Oncology/Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

View Article and Find Full Text PDF
April 2014

Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma.

Clin Lymphoma Myeloma Leuk 2013 Aug 15;13(4):417-23. Epub 2013 Jun 15.

Department of Internal Medicine Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE, USA.

View Article and Find Full Text PDF
August 2013

International analysis of the frequency and outcomes of NK/T-cell lymphomas.

Best Pract Res Clin Haematol 2013 Mar 24;26(1):23-32. Epub 2013 May 24.

Department of Medicine, Division of Hematology and Hematology, University Hospitals Seidman Cancer Center, Case Western Reserve University, 11100 Euclid Ave. LKS 5079, Cleveland, OH 44106, USA.

View Article and Find Full Text PDF
March 2013

Epigenetic therapy in allogeneic hematopoietic stem cell transplantation.

Rev Bras Hematol Hemoter 2013 ;35(2):126-33

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
June 2013

Advances in conditioning regimens for older adults undergoing allogeneic stem cell transplantation to treat hematologic malignancies.

Drugs Aging 2013 Jun;30(6):373-81

Department of Medicine (Division of Hematology and Oncology) and Stem Cell Transplant Program, University Hospitals Seidman Center and Case Western Reserve University, Cleveland, OH, USA.

View Article and Find Full Text PDF
June 2013

Brain metastasis and leptomeningeal carcinomatosis in a patient with cholangiocarcinoma.

Gastrointest Cancer Res 2011 Jul;4(4):144-5

Section of Oncology/Hematology University of Nebraska Medical Center Omaha, NE.

View Article and Find Full Text PDF
July 2011

Small lymphocytic lymphoma in a patient with CREST syndrome.

Hematol Oncol Stem Cell Ther 2011 ;4(3):132-5

University of Nebraska Medical Center and Omaha Veterans Affairs Medical Center, Omaha, Nebraska 68198-7680, USA.

View Article and Find Full Text PDF
February 2012

I-131 tositumomab.

Expert Opin Biol Ther 2010 Aug;10(8):1271-8

Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE 68198-7680. USA.

View Article and Find Full Text PDF
August 2010

Hyposplenism: a comprehensive review. Part I: basic concepts and causes.

Hematology 2007 Feb;12(1):1-13

Department of Medicine, Eastern Maine Medical Center, Bangor, ME 04401, USA.

View Article and Find Full Text PDF
February 2007

Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.

Pol J Pharmacol 2004 Jul-Aug;56(4):445-9

Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Abbassia, Cairo, Egypt.

View Article and Find Full Text PDF
May 2005